Obesity Featured Articles
-
Validating A Better ALS Biomarker With Coya’s Fred Grossman
4/24/2024
Coya Therapeutics President and CMO Fred Grossman, DO, FAPA discusses a potential new biomarker for ALS — 4-HNE, an oxidative stress biomarker — and how it could be more effective than the current standard, NfL.
-
For Veteran PI, Research Requires Motivation, Dedication, And CRO Support
4/23/2024
Principal investigator Dr. Luke Twelves discusses how he remained motivated to continue conducting trials and shares insights into what he thinks will inspire others to do the same.
-
Will Today’s Clinical Trial Trends Become Tomorrow’s Routine?
4/23/2024
Clinical trial trends can be divided into two groups — those related to changes in the conduct of clinical trials and those related to the changes in therapeutic areas. Will these trends hold steady as 2024 unfolds?
-
4 Ways Concomitant Medications Can Complicate Your Trial
4/22/2024
Concomitant medications (con-meds) significantly influence clinical trials, affecting duration, costs, and participant safety. However, they are often inadequately tracked and analyzed in studies.
-
10 Reasons To Avoid Using Excel For Clinical Trials
4/22/2024
As clinical trials become increasingly complex and global, learn why abandoning Excel for specialized applications becomes imperative for efficiency, accuracy, and cost-effectiveness.
-
10 Tips For Enabling Better Sponsor-CRO Collaborations
4/22/2024
By following these tips and investing in software tools, sponsors and CROs can optimize their partnerships and achieve greater success, leading to increased resource productivity and cost savings.
-
Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch
4/22/2024
The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.
-
Backup Sites: The Closers Of Clinical Trials
4/22/2024
With the rising complexity of trials and dwindling site availability, the adoption of backup sites has become increasingly commonplace, reflecting the industry's commitment to maximizing recruitment potential.
-
Diversity In Clinical Trials: Walking The Walk
4/22/2024
Discover why achieving true diversity demands more than rhetoric—requiring genuine engagement, cultural humility, and a commitment to understanding and addressing the unique needs of marginalized communities.
-
Why Can’t We Compare Site Performance Measures?
4/22/2024
Cerdi Beltré believes it’s possible to develop a global and objective way to measure investigator site performance for metrics such as startup duration, screen-pass rates, or rate of enrollment. It just won’t be easy … or make some sites happy.